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Background: The study aims to elucidate the putative association between various forms of dementia, including
Alzheimer’s disease, primary open-angle glaucoma and Helicobacter pylori (H.pylori) infection in all possible combinations.
Methods: We prospectively recruited for the study 156 patients, divided into a dementia group, a glaucoma group
and two control groups. All patients were submitted to neuropsychological evaluation aiming to detect dementia,
ophthalmological examination, aiming to detect glaucoma, and H.pylori diagnostic testing. The provided data were
analyzed with the question of possible correlation between the aforementioned entities.
Results: Positive correlations were found between Hp infection and dementia, Hp infection and glaucoma, as well as
between dementia and glaucoma.
Conclusions: The study confirmed the hypothesis that neurodegenerative diseases such as dementia and glaucoma
are linked to each other and to H.pylori infection.
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Alzheimer’s disease (AD), the main cause of dementia,
affects more than 30 million people worldwide, with a
rising tendency towards the number of 100 million
patients estimated to suffer from the disease in the year
2050 [1,2]. Primary open angle glaucoma (POAG) is the
second cause of blindness worldwide [3]. H. pylori is a
common, Gram-negative bacterium found in the stomach.
It has been shown to elicit an inflammatory response (gas-
tritis) by altering stomach pH, and by secreting proteases
and VacA. It has also been implicated in the development
of gastroduodenal ulcer, gastric cancer, MALT-lymphoma
and colorectal cancer [4-8].
Neurodegenerative disorders are believed to be linked
to each other as well as to H.pylori infection in terms of
epidemiology and etiology [9-13]. However, various stud-
ies investigating the issue have concluded to contradict-
ory results [14-16]. For this reason, aim of the current
prospective study is to elucidate the putative associ-
ation between Alzheimer’s disease and other dementias
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unless otherwise stated.disease-PD, Lewy body dementia-LB), primary open-angle
glaucoma (POAG) and H.pylori infection in all possible
combinations, based on a wide range of diagnostic proce-
dures, that would set the diagnosis of each disorder with
accuracy and beyond doubt.
Methods
The study was performed in compliance with the
Helsinki Declaration and after the approval of the Ethics
Committee of the Aristotle University of Thessaloniki.
The patients, whose informed consent was obtained prior
to the initiation of the study were divided in the following
groups:
i. A group of patients with dementia (60 patients),
which included patients with official diagnosis of AD
(36 patients), PD (9 patients), LB (9 patients), FTD
(6 patients) [17-20].
ii. A group of patients with POAG (35 patients).
iii. A control group of 31 subjects found negative for
dementia and glaucoma. They were used for the
analysis of Hp infection incidence in patients with
dementia and glaucoma.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Comparative data regarding age and gender between patients with dementia, glaucoma and the subjects of











Age 61.34 ± 6.526 62.18 ± 5.04 62.41 ± 4.49 61.48 ± 2.8 p > 0,05
Male patients 28 (46.66%) 14 (46.66%) 14 (45.16%) 13 (43.44%) p > 0,05
The table shows comparative data in regard to age and gender between the patients with dementia, glaucoma and the patients of the two control groups. The
comparison was performed with the non parametric Mann–Whitney-Wilcoxon test for the age analysis and the x2 for the gender distribution. The level of statistical
significance was set at a threshold for p < 0.05.
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an emergency ophthalmology department, used for the
analysis of correlation between dementia and glaucoma.
Neuropsychological battery
All participants were checked for dementia with the ap-
plication of a neuropsychological battery consisting of the
Mini Mental State Examination, the Functional Rating
Scale for Symptoms of Delirium, the Neuropsychiatric
Inventory, the Hindi Mental State Examination and the
Geriatric Depression Scale [21-28].
Ophthalmological examination
The ocular examination was based on visual acquity con-
trol (reading of an optotype from a distance of 5 meters),
tonometry with a Goldmann’s applanation tonometer [29]
after application of a local anesthetic (hydrochloric proxy-
metacaine 0.5%), and fundoscopy after the application of
tropicamide solution 0.5% and of the a-adrenergic stimu-
lator phenylefrine in a solution of 5%. The examination
was concluded with a control of visual fields in a static per-
imetry apparatus type Octopus 900 (Haag-Streit, Switzerland).Table 2 Helicobacter pylori infection in patients with









41/60 68.33 14/31 45.16 p < 0.05
Alzheimer’s
disease












66.67 15/31 45.16 p < 0.05
6/9
The table depicts comparative data between patients with dementia in total and
per diagnosis and members of the control group in regard to Hp infection. For
the statistical analysis the x2 criterion was applied. The level of statistical
significance was set at a threshold for p < 0.05.Diagnostic criteria for glaucoma were the ones provided
by the Thessaloniki Eye Study [30].
Helicobacter pylori infection diagnosis
The examination for the Hp infection was based on
gastroscopy and histological examination of the retrieved
tissue specimens. Gastroscopy was performed after in-
duction of sedation with midazolame (Dormicum) in an
iv. administration and in a dosage of 3–5 mg, according
to the patient’s weight. This was followed by application
of xylocaine to the nasopharynx in a spray form. The
endoscopic instrument that was used for the research
was an Olympus gastroscope.
Histological examination of the tissue specimens was
based on a Cresyl-Violet staining. In a small number of
patients (5), who couldn’t be submitted to endoscopy due
to lack of cooperation, we performed a serological exam-
ination of IgG antibodies against H.pylori.
Statistical analysis
The statistical analysis was based for the comparison of
percentages on the x2 criterion. For the quantitative
parameters the analysis was based on the non parametric
Mann–Whitney-Wilcoxon test. The quantitative parame-
ters were expressed as mean ± standard deviation. The
levels for statistical significance were set for values of
p < 0.05. The program we used for the statistical analysis
was the SPSS 21.0 v.
Results and discussion
The study concluded to positive correlations between HP
infection and dementia and H.pylori infection and glau-
coma. This was expressed as an augmented frequency of












24/35 68.57% 14/31 45.16 p < 0.05
The table shows comparative data between patients with glaucoma and subjects
of the control group in regard to Hp infection. For the statistical analysis the x2
criterion was applied. The level of statistical significance was set at a value
for p < 0.05.
Table 4 Frequency of glaucoma in patients with dementia – frequency of glaucoma in patients of the control group
Patients with dementia Percentage in % Control group Percentage in % Statistical
significance
10/60 16.66 The control group had
no members with glaucoma
The control group had
no members with glaucoma
p < 0.01
Patients with Alzheimer’s disease 19.44
7/36
Patients with Parkinson’s dementia 33.33
3/9
The table shows comparative data regarding the frequency of glaucoma in patients with dementia and control group. The control group had no members with
glaucoma. For the statistical analysis the x2 criterion was applied. The level of statistical significance was set at a value for p < 0.05.
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dementia vs 45.16%, p < 0.05, 68.57% in patients with glau-
coma vs 45.16%, p < 0.05). It has also shown a positive
correlation between dementia and glaucoma, both in the
form of augmented frequency of glaucoma in patients
with AD and PD (16.66% vs 0%,) as well as in the form of
augmented frequency of dementia (AD and FTD) in pa-
tients with glaucoma (16.66% vs 0%), in comparison to the
frequency in the control group. The aforementioned find-
ings are depicted in Tables 1, 2, 3, 4 and 5.
The positive findings of the study in regard to the
association of dementia (particularly AD) and Hp infec-
tion, POAG and H.pylori infection and finally, between
dementia and POAG come to confirm the related con-
clusions reached by Kountouras et al. [9,11,12] and Bayer
et al. [13].
Which common pathophysiological pathways stand
behind the examined entities is not yet known. A possible
explanation is that H.pylori infection initiates mechanisms
of humoral and cellular immune response, which create
crossreactions due to common genetic components with
the ones found in nerve tissue; what follows are apoptosis-
related mechanisms of cell destruction which are frequent
in neurodegenerative diseases, such as dementia and glau-
coma [31].
Another theory that might explain the findings of the























The table shows comparative data regarding the frequency of dementia in
patients with glaucoma and control patients. The control group members had
no dementia. For the statistical analysis the x2 criterion was applied. The level
of statistical significance was set at a value for p < 0.05.blood–brain barrier in patients with neurodegenerative
diseases, such as multiple sclerosis [32,33]; this phenomenon
may give to the H.pylori the chance to enter the barrier
and accelerate or influence their course. Similarly, Deretzi
et al. have recently [34] proposed a theory that H.pylori
or other pathogens may follow a distinct pathway to
bypass the blood–brain barrier and cause damage to
the brain. More specifically, they use the gastrointes-
tinal tract (GIT) retrograde axonal transport through
sensory or motor fibres in order to invade the central
nervous system.
The findings of the study may have important practical
applications for our patients in the future. They may
lead to a widely accepted eradication of H.pylori as a
measure for prevention against dementia and glaucoma.
They also may lead to the establishment of routine diag-
nostic examinations for glaucoma in patients with demen-
tia and of dementia in patients with glaucoma, which
would influence the quality of life of these patients posi-
tively. Continued research in this field in the epidemio-
logical, but more intensely in the molecular level, might
further clarify common biochemical pathways linking
dementia, glaucoma and Hp infection.
Conclusions
i. H.pylori infection is more frequent in patients
suffering from AD and other forms of dementia than
in the general population.
ii. H.pylori infection is more frequent in patients
suffering from POAG than in the general
population.
iii. POAG is more frequent in patients suffering from
dementia (AD and PD) than in the general
population.
iv. Dementia (AD and FTD) is more frequent in
patients with POAG than in the general population.
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